Advertisement
Advertisement
U.S. Markets close in 5 hrs 45 mins
Advertisement
Advertisement
Advertisement
Advertisement

Summit Hotel Properties, Inc. (INN)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
7.04-0.23 (-3.16%)
As of 10:15AM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close7.27
Open7.22
Bid7.09 x 1000
Ask7.10 x 900
Day's Range7.04 - 7.22
52 Week Range6.70 - 10.94
Volume136,107
Avg. Volume961,359
Market Cap749.415M
Beta (5Y Monthly)2.21
PE Ratio (TTM)N/A
EPS (TTM)-1.11
Earnings DateFeb 21, 2022 - Feb 25, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateFeb 13, 2020
1y Target Est12.33
  • Zacks

    Summit Hotel Properties (INN) Moves 7.9% Higher: Will This Strength Last?

    Summit Hotel Properties (INN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

  • Newsfile

    Innocan Reports Successful Preclinical Dog-Trial Results Regarding Pain Management: "It Was as If a New Dog Came into Our Lives"

    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 24, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce successful preclinical trials in dogs with osteoarthritis. A case entailing the clinical condition of Goody, an 8-year-old male mixed-breed dog, who was rescued in a terrible condition after he was found tied up with a very short leash, cachectic and wounded, was published. Goody suffers from ...

  • Newsfile

    Innocan Pharma Announces Filing of PCT Patent Application for Vaginal Atrophy Treatment

    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 17, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce that it has filed a new PCT patent application entitled "Compositions for Treatment of Vaginal Atrophy" on June 12, 2022, claiming priority from a US provisional patent. Vaginal atrophy is a condition associated with loss of moisture, thinning, and inflammation of the vaginal walls, which can ...

Advertisement
Advertisement